Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/352| Rapid implementation of mobile technology for real-time epidemiology of COVID-19 | |
| COPE Consortium Long H. Nguyen Claire J. Steves Jonathan Wolf Tim D. Spector Andrew T. Chan David A. Drew | |
| Novel Coronavirus | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1101/2020.04.02.20051334 | |
| The rapid pace of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (COVID-19) presents challenges to the robust collection of population-scale data to address this global health crisis. We established the COronavirus Pandemic Epidemiology (COPE) consortium to bring together scientists with expertise in big data research and epidemiology to develop a COVID-19 Symptom Tracker mobile application that we launched in the UK on March 24, 2020 and the US on March 29, 2020 garnering more than 2.25 million users to date. This mobile application offers data on risk factors, herald symptoms, clinical outcomes, and geographical hot spots. This initiative offers critical proof-of-concept for the repurposing of existing approaches to enable rapidly scalable epidemiologic data collection and analysis which is critical for a data-driven response to this public health challenge. ### Competing Interest Statement TDS is a consultant to Zoe Global Ltd. JW is an employee of Zoe Global Ltd. DAD and ATC previously served as investigators on a clinical trial of diet and lifestyle using a distinct mobile application that was supported by Zoe Global Ltd. Other authors have no conflict of interest to declare. ### Clinical Trial NCT04331509 ### Clinical Protocols <http://www.monganinstitute/cope-consortium> ### Funding Statement ATC is the Stuart and Suzanne Steele MGH Research Scholar. Development of the COVID Symptom Tracker mobile app was supported in kind by Zoe Global Limited and grants from the Wellcome Trust (212904/Z/18/Z). ### Author Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes We welcome anyone who would like access to this growing dataset to join the COPE Consortium to gain access to the data following completion of a data use agreement. Details with how to become a member can be found at http://www.monganinstitute.org/cope-consortium. | |
| Cold Spring Harbor Laboratory Press | |
| 2020 | |
| Preimpreso | |
| https://www.medrxiv.org/content/10.1101/2020.04.02.20051334v1 | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| Rapid implementation of mobile.pdf | 565.03 kB | Adobe PDF | Visualizar/Abrir |